ONE EXPERIENCE (ALEXP.PA) Stock Fundamental Analysis

EPA:ALEXP • FR0013266772

0.625 EUR
+0.09 (+17.92%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall ALEXP gets a fundamental rating of 3 out of 10. We evaluated ALEXP against 57 industry peers in the Hotels, Restaurants & Leisure industry. ALEXP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALEXP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ALEXP has reported negative net income.
  • In the past year ALEXP had a positive cash flow from operations.
  • ALEXP had negative earnings in each of the past 5 years.
  • ALEXP had a positive operating cash flow in 4 of the past 5 years.
ALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFALEXP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -500K -1M

1.2 Ratios

  • ALEXP's Return On Assets of -2.56% is on the low side compared to the rest of the industry. ALEXP is outperformed by 68.42% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.42%, ALEXP is in line with its industry, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
ROA -2.56%
ROE -5.42%
ROIC N/A
ROA(3y)-6.05%
ROA(5y)-4.79%
ROE(3y)-12.31%
ROE(5y)-9.23%
ROIC(3y)N/A
ROIC(5y)N/A
ALEXP.PA Yearly ROA, ROE, ROICALEXP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

  • ALEXP has a Gross Margin (47.42%) which is in line with its industry peers.
  • ALEXP's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALEXP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.2%
GM growth 5YN/A
ALEXP.PA Yearly Profit, Operating, Gross MarginsALEXP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ALEXP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALEXP remains at a similar level compared to 1 year ago.
  • ALEXP has a better debt/assets ratio than last year.
ALEXP.PA Yearly Shares OutstandingALEXP.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALEXP.PA Yearly Total Debt VS Total AssetsALEXP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • ALEXP has an Altman-Z score of 0.38. This is a bad value and indicates that ALEXP is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.38, ALEXP is not doing good in the industry: 71.93% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of ALEXP is 3.10, which is a good value as it means it would take ALEXP, 3.10 years of fcf income to pay off all of its debts.
  • ALEXP has a Debt to FCF ratio of 3.10. This is in the better half of the industry: ALEXP outperforms 75.44% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that ALEXP is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.30, ALEXP belongs to the top of the industry, outperforming 80.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 3.1
Altman-Z 0.38
ROIC/WACCN/A
WACC6.81%
ALEXP.PA Yearly LT Debt VS Equity VS FCFALEXP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

  • ALEXP has a Current Ratio of 1.03. This is a normal value and indicates that ALEXP is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.03, ALEXP is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Quick Ratio of 1.03 indicates that ALEXP should not have too much problems paying its short term obligations.
  • The Quick ratio of ALEXP (1.03) is better than 70.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
ALEXP.PA Yearly Current Assets VS Current LiabilitesALEXP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • ALEXP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.91%, which is quite impressive.
  • ALEXP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.75%.
  • The Revenue has been growing by 28.24% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.96%
Revenue 1Y (TTM)-26.75%
Revenue growth 3Y28.24%
Revenue growth 5YN/A
Sales Q2Q%8.13%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEXP.PA Yearly Revenue VS EstimatesALEXP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ALEXP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEXP.PA Price Earnings VS Forward Price EarningsALEXP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALEXP indicates a somewhat cheap valuation: ALEXP is cheaper than 75.44% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.96
EV/EBITDA N/A
ALEXP.PA Per share dataALEXP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALEXP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ONE EXPERIENCE

EPA:ALEXP (2/20/2026, 7:00:00 PM)

0.625

+0.09 (+17.92%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.29%
Inst Owner ChangeN/A
Ins Owners29.55%
Ins Owner ChangeN/A
Market Cap7.34M
Revenue(TTM)4.45M
Net Income(TTM)-369.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.65
P/FCF 10.96
P/OCF 10.6
P/B 1.08
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY9.12%
OCF(TTM)0.06
OCFY9.44%
SpS0.38
BVpS0.58
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.56%
ROE -5.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.42%
FCFM 15.06%
ROA(3y)-6.05%
ROA(5y)-4.79%
ROE(3y)-12.31%
ROE(5y)-9.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.2%
GM growth 5YN/A
F-Score6
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr 6.27%
Cap/Sales 0.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 0.38
F-Score6
WACC6.81%
ROIC/WACCN/A
Cap/Depr(3y)140.15%
Cap/Depr(5y)136.56%
Cap/Sales(3y)11.71%
Cap/Sales(5y)20.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.75%
Revenue growth 3Y28.24%
Revenue growth 5YN/A
Sales Q2Q%8.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y193.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y188.75%
OCF growth 3Y74.44%
OCF growth 5YN/A

ONE EXPERIENCE / ALEXP.PA FAQ

Can you provide the ChartMill fundamental rating for ONE EXPERIENCE?

ChartMill assigns a fundamental rating of 3 / 10 to ALEXP.PA.


Can you provide the valuation status for ONE EXPERIENCE?

ChartMill assigns a valuation rating of 1 / 10 to ONE EXPERIENCE (ALEXP.PA). This can be considered as Overvalued.


What is the profitability of ALEXP stock?

ONE EXPERIENCE (ALEXP.PA) has a profitability rating of 1 / 10.


Can you provide the financial health for ALEXP stock?

The financial health rating of ONE EXPERIENCE (ALEXP.PA) is 5 / 10.